Objective
In recent years the presence of pharamceuticals (PhAcs) in wastewater treatment plant effluents, drinking water and groundwater has become an issue of emerging concern.The global concentration of these compounds constitutes an effluent organic matter which often serves as precursor for the formation of hazardous disinfection by-products during conventional water disinfection processes. The potential effects of pharmaceutically active compounds on humans and aquatic ecosystems are not completely understood, especially if it is considered that PhACs co-exist in mixtures with other compounds (chemical “cocktails”).The uncontrolled release of antibiotics to the environment promotes the selection of antibiotic resistance genes (ARGs) and antibiotic-resistant bacteria (ARB), which shade further long-term health risks to humans and animals To address this challenge, the application of advanced oxidation processes (AOPs) for the removal of residual organic matter and microorganisms has become an emerging area of research. In order to overcome the limitation of individuals AOPs the simultaneous application of light based AOPs looks quite interesting. However, in spite of the progress made in fundamental research at bench scale, the practical achievements in the field of environmental photocatalysis have been modest. The PreSTO project deals with the development and demonstration of pilot plants hybrid photocatalytic processes for the simultaneous removal of pathogens & pharmaceuticals from real wastewater effluents. This will be achieved with a step by step investigation of all relevant aspects, including: (a)development of efficient hybrid advanced oxidation processes (i) Cavitation/Solar photo-Fenton and (ii) Solar photo-ElectroFenton at the unique facilities of CIEMAT SPA (b)development & optimization of state of the art analytical methods and biological assays;(c) photocatalytic evaluation for the elimination of antibiotics and pathogens at hybrid pilot scale reactor.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- engineering and technology environmental engineering water treatment processes wastewater treatment processes
- natural sciences chemical sciences catalysis photocatalysis
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs antibiotics
- natural sciences earth and related environmental sciences hydrology limnology
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance antibiotic resistance
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
28040 MADRID
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.